arrow
Back
S

Scott S. Emerson

university of washington

58H-index
209Paper Count
1.7WCitation Count
Published Papers 56
Publication Date
Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial – Authors' reply
err2026-04-23
err0
PREAI
errJohn Deanfield; Scott S Emerson; Søren Rasmussen; Signe Stensen; A Michael Lincoff
errShare
errSave
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials
err2026-04-13
err0
errOAAI
errDirk Müller-Wieland; Darren K. McGuire; A. Michael Lincoff; John B. Buse; Johannes F. E. Mann; Silvio E. Inzucchi; Rodica Pop-Busui; Sharon L. Mulvagh; Scott S. Emerson; Neil R. Poulter; John E. Deanfield; Nikolaus Marx
errShare
errSave
Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT Trial
err2026-01-19
err0
errOAAI
errMartin Bøg; Anders Bo Bojesen; Scott Emerson; Milana Ivkovic; Nia C. Jenkins; Christopher Lübker; Muhammad Mamdani; Thomas Padgett; Luc Van Gaal; Peter E. Weeke; A. Michael Lincoff
errShare
errSave
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
err2025-10-22
err0
errOAAI
errJohn Deanfield; A Michael Lincoff; Steven E Kahn; Scott S Emerson; Ildiko Lingvay; Benjamin M Scirica; Jorge Plutzky; Robert F Kushner; Helen M Colhoun; G Kees Hovingh; Signe Stensen; Peter E Weeke; Ole Kleist Jeppesen; Rafael Bravo; Chau-Chung Wu; Issei Komuro; Ferruccio Santini; Jøran Hjelmesæth; Miguel Urina-Triana; Silvio Buscemi; Donna H Ryan
errShare
errSave
The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes
err2025-03-01
err0
errOAAI
errLubker, Christopher; Bhavsar, Jigish; do Vale, Ruben Duque; Emerson, Scott S.; Nortoft, Emil; Plutzky, Jorge; Roberts, Geraint; Tarp, Jens Magelund; Lincoff, A. Michael
errShare
errSave
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
errLANCET
IF88.5
err2024-09-01
err9
PREAI
errKosiborod, Mikhail N.; Deanfield, John; Pratley, Richard; Borlaug, Barry A.; Butler, Javed; Davies, Melanie J.; Emerson, Scott S.; Kahn, Steven E.; Kitzman, Dalane W.; Lingvay, Ildiko; Mahaffey, Kenneth W.; Petrie, Mark C.; Plutzky, Jorge; Rasmussen, Soren; Ronnback, Cecilia; Shah, Sanjiv J.; Verma, Subodh; Weeke, Peter E.; Lincoff, A. Michael
errShare
errSave
Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial
err2024-06-22
err7
errOAAI
errKahn, Steven E.; Deanfield, John E.; Jeppesen, Ole Kleist; Emerson, Scott S.; Boesgaard, Trine Wellov; Colhoun, Helen M.; Kushner, Robert F.; Lingvay, Ildiko; Burguera, Bartolome; Gajos, Grzegorz; Horn, Deborah Bade; Hramiak, Irene M.; Jastreboff, Ania M.; Kokkinos, Alexander; Maeng, Michael; Matos, Ana Laura S. A.; Tinahones, Francisco J.; Lincoff, A. Michael; Ryan, Donna H.
errShare
errSave
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
err2023-12-14
err610
errOAAI
errLincoff, A. Michael; Brown-Frandsen, Kirstine; Colhoun, Helen M.; Deanfield, John; Emerson, Scott S.; Esbjerg, Sille; Hardt-Lindberg, Soren; Hovingh, G. Kees; Kahn, Steven E.; Kushner, Robert F.; Lingvay, Ildiko; Oral, Tugce K.; Michelsen, Marie M.; Plutzky, Jorge; Tornoe, Christoffer W.; Ryan, Donna H.
errShare
errSave
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
errOBESITY
IF4.7
err2022-12-10
err66
errOAAI
errLingvay, Ildiko; Brown-Frandsen, Kirstine; Colhoun, Helen M.; Deanfield, John; Emerson, Scott S.; Esbjerg, Sille; Hardt-Lindberg, Soren; Hovingh, G. Kees; Kahn, Steven E.; Kushner, Robert F.; Lincoff, A. Michael; Marso, Steven P.; Fries, Tea Monk; Plutzky, Jorge; Ryan, Donna H.
errShare
errSave
Revisiting FDA Approval of Aducanumab
err2021-08-26
err122
PREAI
errAlexander, G. Caleb; Knopman, David S.; Emerson, Scott S.; Ovbiagele, Bruce; Kryscio, Richard J.; Perlmutter, Joel S.; Kesselheim, Aaron S.
errShare
errSave
Quantifying pulmonary perfusion from noncontrast computed tomography
err2021-03-11
err17
errOAAI
errCastillo, Edward; Nair, Girish; Turner-Lawrence, Danielle; Myziuk, Nicholas; Emerson, Scott; Al-Katib, Sayf; Westergaard, Sarah; Castillo, Richard; Vinogradskiy, Yevgeniy; Quinn, Thomas; Guerrero, Thomas; Stevens, Craig
errShare
errSave
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
err2020-11-01
err162
errOAAI
errRyan, Donna H.; Lingvay, Ildiko; Colhoun, Helen M.; Deanfield, John; Emerson, Scott S.; Kahn, Steven E.; Kushner, Robert F.; Marso, Steve; Plutzky, Jorge; Brown-Frandsen, Kirstine; Gronning, Marianne O. L.; Hovingh, G. Kees; Holst, Anders Gaarsdal; Ravn, Henrik; Lincoff, A. Michael
errShare
errSave
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)
err2019-04-15
err16
errOAAI
errPratley, Richard E.; Emerson, Scott S.; Franek, Edward; Gilbert, Matthew P.; Marso, Steven P.; McGuire, Darren K.; Pieber, Thomas R.; Zinman, Bernard; Hansen, Charlotte T.; Hansen, Melissa V.; Mark, Thomas; Moses, Alan C.; Buse, John B.
errShare
errSave
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
err2019-04-01
err8
errOAAI
errBrown-Frandsen, Kirstine; Emerson, Scott S.; McGuire, Darren K.; Pieber, Thomas R.; Poulter, Neil R.; Pratley, Richard E.; Zinman, Bernard; Ranthe, Mattis F.; Gron, Randi; Lange, Martin; Moses, Alan C.; Orsy, Petra; Buse, John B.
errShare
errSave
Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use-A DEVOTE Subanalysis
err2018-07-01
err1
PREAI
errBrown-Frandsen, Kirstine; Emerson, Scott S.; Marso, Steven P.; Mcguire, Darren K.; Pieber, Thomas R.; Poulter, Neil R.; Zinman, Bernard; Gron, Randi; Lange, Martin; Moses, Alan C.; Orsy, Petra; Ranthe, Mattis F.; Pratley, Richard E.
errShare
errSave
Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (=65 Years) with Type 2 Diabetes (T2D)-Observations from DEVOTE
err2018-07-01
err0
PREAI
errPratley, Richard E.; Emerson, Scott S.; Franek, Edward; Gilbert, Matthew P.; Marso, Steven P.; Mcguire, Darren K.; Pieber, Thomas R.; Poulter, Neil R.; Hansen, Charlotte T.; Hansen, Melissa V.; Mark, Thomas; Moses, Alan C.; Zinman, Bernard
errShare
errSave
Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) DEVOTE 1
err2016-09-01
err48
errOAAI
errMarso, Steven P.; McGuire, Darren K.; Zinman, Bernard; Poulter, Neil R.; Emerson, Scott S.; Pieber, Thomas R.; Pratley, Richard E.; Haahr, Poul-Martin; Lange, Martin; Frandsen, Kirstine Brown; Rabol, Rasmus; Buse, John B.
errShare
errSave
Shielding Artificially Increases the Attenuation of Water: Study of CT Gradient Attenuation Induced by Shielding (CT GAINS)
err2013-02-01
err4
PREAI
errGoldin, Dmitry; Emerson, Scott; Farah, Michael C.; Sokhandon, Farnoosh; Nandalur, Kiran R.; Kumar, Shawn; Mezwa, Duane G.
errShare
errSave
The Prevention and Treatment of Missing Data in Clinical Trials
err2012-10-04
err1.1K
errOAAI
errLittle, Roderick J.; D'Agostino, Ralph; Cohen, Michael L.; Dickersin, Kay; Emerson, Scott S.; Farrar, John T.; Frangakis, Constantine; Hogan, Joseph W.; Molenberghs, Geert; Murphy, Susan A.; Neaton, James D.; Rotnitzky, Andrea; Scharfstein, Daniel; Shih, Weichung J.; Siegel, Jay P.; Stern, Hal
errShare
errSave